Fidelity Investments
KZR

Fidelity Investments’s Kezar Life Sciences KZR Stock Holding History

Fidelity Investments’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.7K Buy
10,208
+10,000
+4,808% +$65.1K ﹤0.01% 3922
2025
Q4 		$1.31K Sell
208
-8,524
-98% -$49.7K ﹤0.01% 5072
2025
Q3 		$34.1K Sell
8,732
-13,933
-61% -$57.1K ﹤0.01% 4146
2025
Q2 		$104K Buy
22,665
+8,360
+58% +$35.8K ﹤0.01% 3596
2025
Q1 		$69.8K Buy
14,305
+5,904
+70% +$35.8K ﹤0.01% 3710
2024
Q4 		$56.5K Buy
8,401
+8,080
+2,517% +$60.2K ﹤0.01% 3794
2024
Q3 		$2.48K Sell
321
-5,908
-95% -$35.6K ﹤0.01% 4759
2024
Q2 		$37.4K Buy
6,229
+4,020
+182% +$30.6K ﹤0.01% 3772
2024
Q1 		$19.9K Buy
2,209
+358
+19% +$3.26K ﹤0.01% 4022
2023
Q4 		$17.5K Buy
1,851
+1,120
+153% +$9.85K ﹤0.01% 4009
2023
Q3 		$8.7K Sell
731
-3,186
-81% -$56.5K ﹤0.01% 4156
2023
Q2 		$96K Sell
3,917
-163
-4% -$4.24K ﹤0.01% 3180
2023
Q1 		$128K Sell
4,080
-4,473
-52% -$259K ﹤0.01% 3120
2022
Q4 		$602K Sell
8,553
-2,802
-25% -$208K ﹤0.01% 2663
2022
Q3 		$978K Buy
11,355
+26
+0.2% +$2.53K ﹤0.01% 2612
2022
Q2 		$937K Buy
11,329
+7,306
+182% +$644K ﹤0.01% 2688
2022
Q1 		$669K Buy
+4,023
New +$577K ﹤0.01% 2900
2021
Q2 		– Sell
-134,674
Closed -$8.03M – 4598
2021
Q1 		$8.03M Sell
134,674
-51,899
-28% -$3.03M ﹤0.01% 2115
2020
Q4 		$9.74M Hold
186,573
– – ﹤0.01% 1981
2020
Q3 		$9.03M Sell
186,573
-7,180
-4% -$343K ﹤0.01% 1865
2020
Q2 		$10M Sell
193,753
-50,687
-21% -$2.56M ﹤0.01% 1809
2020
Q1 		$10.7M Sell
244,440
-42,685
-15% -$1.74M ﹤0.01% 1674
2019
Q4 		$11.5M Buy
287,125
+5,982
+2% +$184K ﹤0.01% 1800
2019
Q3 		$9.22M Sell
281,143
-5,648
-2% -$273K ﹤0.01% 1867
2019
Q2 		$22.1M Buy
286,791
+11,158
+4% +$1.74M ﹤0.01% 1581
2019
Q1 		$48.9M Sell
275,633
-9,290
-3% -$1.83M 0.01% 1226
2018
Q4 		$67.2M Buy
284,923
+31,885
+13% +$7.79M 0.01% 1031
2018
Q3 		$54.2M Buy
253,038
+102,780
+68% +$17.9M 0.01% 1234
2018
Q2 		$26M Buy
+150,258
New +$26.2M ﹤0.01% 1605

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Fidelity Investments's KZR Position: Q1 2026 in Review

Fidelity Investments increased its Kezar Life Sciences (KZR) stake by 4,808% in Q1 2026, buying an estimated $65.1K and bringing the position to 10,208 shares worth $75.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3922.

Fidelity Investments first reported a position in KZR in Q2 2018 and has held it in 29 quarters since. The position peaked at $67.2M in Q4 2018. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Fidelity Investments held 10,208 shares of Kezar Life Sciences worth $75.7K as of Q1 2026.
  • Fidelity Investments bought 10,000 Kezar Life Sciences shares in Q1 2026, an estimated $65.1K.
  • Kezar Life Sciences made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3922 holding.
  • Fidelity Investments first reported a position in Kezar Life Sciences in Q2 2018 and has held it in 29 quarters since.
  • Fidelity Investments's Kezar Life Sciences position peaked at $67.2M in Q4 2018.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.